Recent Quotes (30 days)

You have no recent quotes
chg | %

Bioquell plc  

(Public, LON:BQE)   Watch this stock  
Find more results forBQE
140.60
-0.40 (-0.28%)
May 24 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 140.60 - 140.60
52 week 125.00 - 162.95
Open 141.00
Vol / Avg. 9,783.00/570.00
Mkt cap 58.76M*
P/E 14.89
Div/yield 3.06/2.18*
EPS 0.09*
Shares 41.79M
Beta     -
Inst. own     -
*GBP
May 13, 2013
Bioquell PLC Interim Management Statement
Mar 19, 2013
Preliminary 2012 Bioquell PLC Earnings Release
  

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 13.12% 9.74%
Operating margin 12.44% 10.24%
EBITD margin - 19.49%
Return on average assets 13.68% 9.72%
Return on average equity 19.46% 13.69%
Employees 431 -
Carbon Disclosure Rating - -

Address

52 Royce Close, West Portway
ANDOVER, ENG SP10 3TS
United Kingdom - Map
+44-1264-835835 (Phone)
+44-1264-835836 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance
Discussion Group - Google Finance

Description

Bioquell PLC is a holding company. The Company is engaged in the principal activities of designing, manufacturing and supplying of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defense industries, and testing, regulatory and compliance services to a range of companies, including the aerospace, telecoms and defense industries. It has two divisions: bio-decontamination (BIO) division is engaged in providing solutions based on hydrogen peroxide vapor technology to eradicate bacteria, viruses and fungi, throughout a range of applications. It also provides chemical, biological, radiological and nuclear defense filtration technology and specialist laboratory filtration equipment, and the TRaC (Testing, Regulatory and Compliance) division provides a range of services that include environmental testing, telecoms testing, radio testing, electromagnetic compatibility testing, safety testing, CE Mark testing and stress analysis.

Officers and directors

Nicholas M. T. Adams Chief Executive, Executive Director
Mark Bodeker Chief Financial Officer, Chief Operating Officer, Executive Director
Georgina Pope Company Secretary
Nigel J. Keen Independent Non-Executive Chairman of the Board
Age: 64
Christopher H. B. Mills Non-Executive Director
Age: 60
Tony R. Bourne Independent Non-Executive Director
Ian Carruthers OBE Independent Non-Executive Director
Simon John Constantine Independent Non-Executive Director
Age: 53